![]() |
市場調查報告書
商品編碼
1943152
避孕套市場-全球產業規模、佔有率、趨勢、機會及預測(依性別、類型、通路、地區及競爭格局分類,2021-2031年)Condom Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Gender, By Type, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球避孕套市場預計將從 2025 年的 122.2 億美元成長到 2031 年的 203.1 億美元,年複合成長率為 8.84%。
保險套是一種鞘狀屏障裝置,通常由乳膠或聚氨酯製成,用於性交過程中以降低意外懷孕的風險並預防感染疾病的傳播。市場的主要促進因素包括性行為感染傳染病發生率的上升和政府嚴格的計劃生育政策。這些因素構成了對價格合理的預防解決方案的持續結構性需求,這種需求不受暫時性消費趨勢的影響,從而確保了全球醫療保健系統對疾病預防產品的基本需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 122.2億美元 |
| 市場規模:2031年 | 203.1億美元 |
| 複合年成長率:2026-2031年 | 8.84% |
| 成長最快的細分市場 | 乳膠保險套 |
| 最大的市場 | 亞太地區 |
然而,國際資金和採購的減少給避孕套市場帶來了巨大挑戰,阻礙了其在關鍵地區的廣泛應用。根據聯合國愛滋病規劃署(UNAIDS)的數據,到2025年,全球公共部門的保險套採購量預計將比2011年的尖峰時段平均下降30%。補貼供應的減少對市場成長構成重大障礙,尤其是在開發中國家。
全球性行為感染感染(STI)和愛滋病毒(HIV)疫情的日益蔓延是推動保險套市場發展的主要動力,因此需要持續穩定的生產量以滿足公共衛生需求。不斷上升的感染率促使衛生組織將屏障避孕器作為第一道防線,確保市場規模不受商業週期波動的影響。根據全球抗愛滋病、結核病和瘧疾基金於2025年9月發布的《2025年績效報告》,2024年全球將新增130萬例愛滋病毒感染病例,凸顯了持續獲得預防措施的重要性。即使在已開發國家,這趨勢也十分明顯。根據HIV.gov的數據,2025年的初步監測數據顯示,2024年美國將新增超過220萬例披衣菌感染、淋病和梅毒病例,這強調了廣泛提供預防性藥物以遏制這些傳播途徑的必要性。
政府主導的計劃生育和疾病預防計畫是第二個關鍵促進因素,透過大規模的機構採購計畫來穩定需求。各國衛生署和國際組織積極補貼並向高風險族群分發預防性藥物,並為生產者建立穩定的供應管道,以抵銷私人零售部門的波動。這些計畫力度尤其大,政府干涉促使疾病負擔重的地區大規模消耗藥品。例如,根據烏干達愛滋病委員會2025年12月發布的報告《烏干達實現97%的愛滋病毒抑制率》,公部門在2024年分發了約2.079億個男用保險套。這些廣泛的公共部門努力確保了核心產業的生產能夠繼續滿足這些規定的供應鏈需求,即使資金籌措狀況改變。
國際資金籌措和採購量的下降對全球避孕套市場的擴張構成重大障礙。資金緊縮直接影響發展中地區的保險套供應,這些地區的市場成長嚴重依賴國際衛生組織的補貼性批量採購。當捐助資金停滯或減少時,供應鏈就會中斷,導致高需求地區出現庫存短缺,這些地區轉向商業零售在經濟上不可行。因此,製造商面臨訂單量不穩定的問題,擾亂生產計畫,降低收入穩定性。
這種對外部援助的依賴造成了脆弱的市場生態系統,極易出現預算短缺。無法獲得穩定的資金籌措限制了預防項目的覆蓋範圍,並有效地阻礙了市場規模的成長。據全球基金稱,國際資金的減少對疾病預防工作的進展構成了嚴重威脅,並導致2024年全球新增130萬例愛滋病毒感染病例。這種關聯性凸顯了資金短缺如何直接導致產品供應減少和市場停滯,從而阻礙了新興經濟體中該產業充分發揮其潛力。
各種增強愉悅感的質地和配方層出不窮,從根本上重塑了市場格局,將消費者的焦點從基本的預防轉向性健康和體驗滿足。製造商正在開發具有刺激性紋理、凸塊和潤滑劑的產品,以增強性快感,旨在吸引與價格敏感的公共部門截然不同的高階客戶群。這種策略透過將保險套作為生活方式產品而非醫療必需品進行行銷,有效地使品牌免受大宗商品價格壓力的影響。根據利潔時集團於2025年10月發布的“2025年第三季業績報告”,新興市場的“私密健康”品類正經歷兩位數的成長,這主要得益於Benzocaine因避孕套等新型高性能創新產品的快速普及。
同時,市場正明顯轉向直接面對消費者(DTC)和訂閱零售模式,以避免國際捐助資金帶來的波動性。儘管機構採購面臨預算限制,但私人零售領域正在擴張,品牌透過電子商務和實體店夥伴關係與消費者建立直接聯繫,並強調品牌忠誠度和供應穩定性。這種商業性韌性抵消了政府採購的下降,並透過持續的私人購買確保了收入穩定。根據Church & Dwight公司2025年10月發布的2025年第三季財報,該公司國內有機銷售額成長了2.3%。這項業績主要得益於其高階Trojan避孕套系列產品零售需求的持續成長。
The Global Condom Market is projected to expand from USD 12.22 Billion in 2025 to USD 20.31 Billion by 2031, reflecting an 8.84% CAGR. A condom is defined as a sheath-shaped barrier device, usually made of latex or polyurethane, used during sexual intercourse to decrease the likelihood of unintended pregnancy and prevent infection transmission. The market is chiefly sustained by core drivers such as the rising incidence of sexually transmitted diseases and strict government family planning initiatives. These factors establish a lasting structural demand for affordable prophylactic solutions that operates independently of temporary consumer trends, ensuring a fundamental need for disease prevention products within international healthcare systems.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 12.22 Billion |
| Market Size 2031 | USD 20.31 Billion |
| CAGR 2026-2031 | 8.84% |
| Fastest Growing Segment | Latex Condom |
| Largest Market | Asia Pacific |
However, the industry confronts a major challenge concerning the decrease in international funding and procurement, which obstructs broad distribution in key regions. Data from the Joint United Nations Programme on HIV/AIDS reveals that in 2025, estimated global public sector condom procurement dropped by an average of 30 percent from the peaks seen in 2011. This contraction in subsidized availability acts as a significant barrier to market volume growth, particularly in developing economies that rely heavily on donor-funded sexual health programs for a steady supply.
Market Driver
The growing global prevalence of sexually transmitted infections (STIs) and HIV acts as a primary catalyst for the condom market, requiring consistent manufacturing output to satisfy public health needs. As infection rates rise, health agencies prioritize barrier methods as a first line of defense, securing steady market volume irrespective of commercial cycles. According to the 'Results Report 2025' by The Global Fund to Fight AIDS, Tuberculosis and Malaria published in September 2025, 1.3 million new HIV infections were recorded globally in 2024, highlighting the crucial need for continued prophylactic access. This trend is also evident in developed nations; HIV.gov reported that provisional surveillance data in 2025 showed over 2.2 million cases of chlamydia, gonorrhea, and syphilis in the United States in 2024, reinforcing the structural necessity to curb these transmission vectors through widespread availability.
Government-led initiatives for family planning and disease prevention serve as a second major driver, stabilizing demand through extensive institutional procurement programs. National health departments and international bodies actively subsidize or freely distribute prophylactics to high-risk groups, creating a reliable volume channel for manufacturers that balances volatility in the private retail sector. These programs are particularly aggressive in regions with high disease burdens, where state intervention results in massive unit consumption. For instance, the Uganda AIDS Commission's 'Uganda Scores 97% HIV Suppression' report from December 2025 noted that public sector distribution of male condoms rose to approximately 207.9 million units in 2024. Such broad public sector commitments ensure that despite funding changes, core industrial output remains engaged to fulfill these mandated supply chains.
Market Challenge
The decline in international funding and procurement poses a critical barrier to the expansion of the Global Condom Market. This financial contraction directly affects the volume of products distributed in developing regions, where market growth depends heavily on subsidized bulk purchasing by global health entities. When donor contributions stagnate or fall, the supply chain fractures, causing immediate stock shortages in high-demand areas that lack the economic ability to shift to commercial retail purchasing. Consequently, manufacturers face unpredictable order volumes, which disrupts production planning and undermines revenue stability.
This reliance on external aid creates a fragile market ecosystem prone to budgetary deficits. The failure to secure consistent financing limits the reach of prevention programs, effectively capping market volume. According to the Global Fund, in 2024, decreasing international funding presented a serious threat to disease prevention progress, contributing to a scenario where 1.3 million new HIV infections were recorded globally. This correlation highlights how funding gaps directly lead to reduced product accessibility and market stagnation, preventing the industry from realizing its full potential in emerging economies.
Market Trends
The diversification of pleasure-enhancing textures and formulations is fundamentally reshaping the market by shifting consumer focus from basic prophylactic utility to sexual wellness and experiential satisfaction. Manufacturers are increasingly engineering products with stimulating ribs, dots, and desensitizing lubricants to attract a premium clientele that operates outside the price-sensitive public sector. This strategy effectively insulates brands from commodity pricing pressures by marketing condoms as lifestyle products rather than medical necessities. According to Reckitt Benckiser Group plc's 'Q3 2025 Trading Update' from October 2025, the company recorded double-digit growth in its Intimate Wellness category within emerging markets, specifically driven by the rapid uptake of new performance-focused innovations such as Benzocaine-infused condoms.
Simultaneously, there is a distinct shift toward direct-to-consumer and subscription-based retail models which circumvents the volatility associated with international donor funding. While institutional procurement faces budgetary constraints, the private retail segment is expanding as brands establish direct relationships with users through e-commerce and physical retail partnerships that emphasize brand loyalty and consistent availability. This commercial robustness provides a counterweight to the declining government tender volumes, ensuring revenue stability through recurring private purchases. According to Church & Dwight Co., Inc.'s 'Q3 2025 Earnings Press Release' from October 2025, the company's domestic organic sales grew by 2.3 percent, a performance primarily led by the sustained retail demand for its premium Trojan condom portfolio.
Report Scope
In this report, the Global Condom Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Condom Market.
Global Condom Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: